3′,5′-Cyclic nucleotide phosphodiesterase
3′,5′-Cyclic nucleotide phosphodiesterase structure
|
Common Name | 3′,5′-Cyclic nucleotide phosphodiesterase | ||
|---|---|---|---|---|
| CAS Number | 9040-59-9 | Molecular Weight | 261.064 | |
| Density | N/A | Boiling Point | 572.9±52.0 °C at 760 mmHg | |
| Molecular Formula | C7H8AsNO5 | Melting Point | N/A | |
| MSDS | USA | Flash Point | 253.4±19.1 °C | |
Use of 3′,5′-Cyclic nucleotide phosphodiesterase3′,5′-Cyclic nucleotide phosphodiesterase is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
| Name | (4-Nitrobenzyl)arsonic acid |
|---|---|
| Synonym | More Synonyms |
| Description | 3′,5′-Cyclic nucleotide phosphodiesterase is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog |
| Boiling Point | 572.9±52.0 °C at 760 mmHg |
|---|---|
| Molecular Formula | C7H8AsNO5 |
| Molecular Weight | 261.064 |
| Flash Point | 253.4±19.1 °C |
| Exact Mass | 260.961853 |
| LogP | -0.25 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Storage condition | 20°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | T |
| RIDADR | NONH for all modes of transport |
|
Increase in cellular cyclic AMP concentrations reverses the profibrogenic phenotype of cardiac myofibroblasts: a novel therapeutic approach for cardiac fibrosis.
Mol. Pharmacol. 84(6) , 787-93, (2013) Tissue fibrosis is characterized by excessive production, deposition, and contraction of the extracellular matrix (ECM). The second messenger cAMP has antifibrotic effects in fibroblasts from several ... |
|
|
Regulation of ecto-apyrase CD39 (ENTPD1) expression by phosphodiesterase III (PDE3).
FASEB J. 27(11) , 4419-28, (2013) The ectoenzyme CD39 suppresses thrombosis and inflammation by suppressing ATP and ADP to AMP. However, mechanisms of CD39 transcriptional and post-translational regulation are not well known. Here we ... |
|
|
Inhibition of phosphodiesterase-1 attenuates cold-induced pulmonary hypertension.
Hypertension 61(3) , 585-92, (2013) Chronic exposure to cold caused pulmonary arterial hypertension (cold-induced pulmonary hypertension [CIPH]) and increased phosphodiesterase-1C (PDE-1C) expression in pulmonary arteries (PAs) in rats.... |
| (4-Nitrobenzyl)arsonic acid |
| Arsonic acid, As-[(4-nitrophenyl)methyl]- |